Patent ID: 8642640

Claim:
A mineralocorticoid receptor antagonist of general formula (I): an N-oxide thereof; a diastereomer, racemate, or compound enriched in a diastereomer thereof; an atropisomer, equal mixture of atropisomers, or compound enriched in an atropisomer thereof; or a pharmaceutically acceptable salt of any of the foregoing, wherein, R 1 represents a C1-C3 alkyl group; R 2 represents a hydroxy-C1-C4 alkyl group, a fluoro-C1-C4 alkyl group, a carbamoyl-C1-C2 alkyl group, a N-mono(C1-C3 alkyl)carbamoyl-C1-C2 alkyl group or a N,N-di(C1-C3 alkyl)carbamoyl-C1-C2 alkyl group; R 3 represents a halogeno group, a C1-C3 alkyl group, a C1-C3 alkoxy group, a halogeno-C1-C3 alkyl group, a halogeno-C1-C3 alkoxy group, a 4-halogenophenyl group or a 4-halogenophenoxy group; R 4 represents a hydrogen atom, a halogeno group or a C1-C3 alkyl group; R 5 represents a sulfamoyl group or a C1-C3 alkylsulfonyl group; and R 6 represents a hydrogen atom, a halogeno group, a C1-C3 alkyl group or a C1-C3 alkoxy group.